(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma

(18)F-fluorodeoxiglucose ((18)F-FDG)-PET/CT has been widely used to evaluate multiple myeloma. (99m)Tc-sestamibi (MIBI) scintigraphy has also been proposed for assessing multiple myeloma, but its use with state-of-the-art single-photon emission computed tomography/computed tomography (SPECT/CT) tech...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nucl Med Commun
Auteurs principaux: Mosci, Camila, Pericole, Fernando V., Oliveira, Gislaine B., Delamain, Marcia T., Takahashi, Maria E.S., Carvalheira, José Barreto C., Etchebehere, Elba C.S.C., Santos, Allan O., Miranda, Eliana C. M., Lima, Mariana C.L., Amorim, Barbara J., de Souza, Carmino A., Lorand-Metze, Irene, Ramos, Celso D.
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2020
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497601/
https://ncbi.nlm.nih.gov/pubmed/32732603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNM.0000000000001259
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires